25 results on '"Trzaskoma A"'
Search Results
2. TIME TO SLEEP IMPROVEMENT IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA TREATED WITH OMALIZUMAB
3. IMPACT OF BASELINE ANGIOEDEMA AND IGE ON RESPONSE TO OMALIZUMAB IN CHRONIC SPONTANEOUS URTICARIA
4. IMPACT OF BASELINE CHARACTERISTICS ON LONG-TERM RESPONSE FOLLOWING OMALIZUMAB TREATMENT IN PATIENTS WITH ALLERGIC ASTHMA
5. Angioedema in the omalizumab chronic idiopathic/spontaneous urticaria pivotal studies
6. Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma
7. PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA MAY BENEFIT FROM LONGER TREATMENT OR UPDOSING WITH OMALIZUMAB
8. EFFECT OF SEX ON RESPONSE TO OMALIZUMAB IN PATIENTS WITH ASTHMA
9. IMPROVEMENTS IN SELECT PATIENT-REPORTED OUTCOMES ARE SIMILAR ACROSS DIFFERENT OMALIZUMAB DOSING REGIMENS
10. TIME TO CLINICALLY MEANINGFUL RESPONSE TO OMALIZUMAB IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA
11. EFFECT OF SEX ON RESPONSE TO OMALIZUMAB IN PATIENTS WITH ASTHMA
12. TIME TO CLINICALLY MEANINGFUL RESPONSE TO OMALIZUMAB IN PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA
13. PATIENTS WITH CHRONIC SPONTANEOUS URTICARIA MAY BENEFIT FROM LONGER TREATMENT OR UPDOSING WITH OMALIZUMAB
14. IMPROVEMENTS IN SELECT PATIENT-REPORTED OUTCOMES ARE SIMILAR ACROSS DIFFERENT OMALIZUMAB DOSING REGIMENS
15. Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO
16. Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO
17. O020 Asthma exacerbations and lung function decline in children during a 52-week controlled trial of omalizumab
18. P144 Exacerbation-free asthma in children treated with omalizumab
19. Baseline asthma burden, comorbidities, and biomarkers in omalizumab-treated patients in PROSPERO
20. Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria
21. P144 Exacerbation-free asthma in children treated with omalizumab
22. P147 Omalizumab reduces healthcare resource use in children
23. O020 Asthma exacerbations and lung function decline in children during a 52-week controlled trial of omalizumab
24. Importance of angioedema-free days in patients with chronic idiopathic or spontaneous urticaria
25. Omalizumab adherence in an observational study of patients with moderate to severe allergic asthma
Catalog
Books, media, physical & digital resources
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.